Manning & Napier Life Sciences (EXLSX)
* As of 28-Feb-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for EXLSX at this time.
|Symbol||% Assets||YTD Return %|
|Oxford Nanopore Technologies Ltd. (United Kingdom)||16.27||N/A|
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.16%|
Performance & Risk
|5y Avg Return:||23.15%|
|Rank in Category (ytd):||100|
|% Rank in Category (ytd):||76.34%|
|Morningstar Risk Rating:||4|
The investment seeks to provide long-term growth by investing principally in the common stocks of companies in the life sciences industry.
The fund will invest, under normal circumstances, at least 80% of its net assets in securities of companies involved in the life sciences industry. Examples of the companies in which the Series may invest include those in the following areas: pharmaceuticals, biotechnology, medical products and supplies, health care services, and environmental services. The fund may invest in U.S. and foreign stocks, including those in emerging markets, ADRs and other U.S. dollar denominated securities of foreign issuers. View More